107 related articles for article (PubMed ID: 10834142)
1. [The reduction of cardiovascular risk with ramipril].
Vanuzzo D
Ital Heart J Suppl; 2000 May; 1(5):713-4. PubMed ID: 10834142
[No Abstract] [Full Text] [Related]
2. The HOPE study: comparison with other trials of secondary prevention.
Otterstad JE; Sleight P
Eur Heart J; 2001 Aug; 22(15):1307-10. PubMed ID: 11465962
[No Abstract] [Full Text] [Related]
3. [Further options with ramipril. Besides cardio- and nephro-protection diabetes prevention, too?].
MMW Fortschr Med; 2003 Sep; 145(39):47. PubMed ID: 14649075
[No Abstract] [Full Text] [Related]
4. ACE inhibitors and high-risk patients.
Myers KA
CMAJ; 2000 Aug; 163(3):327. PubMed ID: 10951738
[No Abstract] [Full Text] [Related]
5. ACE inhibitors to prevent cardiovascular events in high-risk patients.
VandeKieft GK
J Fam Pract; 2000 Apr; 49(4):373-4. PubMed ID: 10778846
[No Abstract] [Full Text] [Related]
6. Don't keep that ACE (inhibitor) up your sleeve! Is ramipril effective for secondary prevention of cardiovascular disease and stroke?
Hammett DC; MacFadyen JC
Can Fam Physician; 2000 Apr; 46():821-3. PubMed ID: 10790814
[No Abstract] [Full Text] [Related]
7. The HOPE Study (Heart Outcomes Prevention Evaluation).
Sleight P
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
[TBL] [Abstract][Full Text] [Related]
8. More than just hype.
Fitchett D
CMAJ; 2003 Jun; 168(13):1646-7; author reply 1647-8. PubMed ID: 12821613
[No Abstract] [Full Text] [Related]
9. More than just hype.
Sigal RJ
CMAJ; 2003 Jun; 168(13):1647; author reply 1647-8. PubMed ID: 12821615
[No Abstract] [Full Text] [Related]
10. [HOPE study].
Katayama S
Nihon Rinsho; 2006 Aug; 64 Suppl 6():475-9. PubMed ID: 16983779
[No Abstract] [Full Text] [Related]
11. More than just hype.
Yusuf S; Dagenais G
CMAJ; 2003 Jun; 168(13):1646; author reply 1647-8. PubMed ID: 12821614
[No Abstract] [Full Text] [Related]
12. Effect of ramipril on cardiovascular events in high-risk patients.
O'Rourke MF; Nichols WW
N Engl J Med; 2000 Jul; 343(1):64-5; author reply 66. PubMed ID: 10896544
[No Abstract] [Full Text] [Related]
13. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
[TBL] [Abstract][Full Text] [Related]
14. ACE inhibition in cardiovascular disease.
Francis GS
N Engl J Med; 2000 Jan; 342(3):201-2. PubMed ID: 10639547
[No Abstract] [Full Text] [Related]
15. Effect of ramipril on cardiovascular events in high-risk patients.
Weinsaft JW
N Engl J Med; 2000 Jul; 343(1):64; author reply 66. PubMed ID: 10896543
[No Abstract] [Full Text] [Related]
16. The renin angiotensin system and cardiovascular disease: hope or hype?
Williams B
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):142-6. PubMed ID: 11967805
[No Abstract] [Full Text] [Related]
17. Vitamin E does not prevent cardiovascular events in high-risk patients.
Flynn T; Stevermer JJ
J Fam Pract; 2000 Apr; 49(4):372-3. PubMed ID: 10778845
[No Abstract] [Full Text] [Related]
18. [The HOPE Study. What does it contribute to general practice?].
Mann J; Sleight P
MMW Fortschr Med; 2000 Nov; 142(47):28-32. PubMed ID: 11143776
[TBL] [Abstract][Full Text] [Related]
19. [Experiences with the realisation of innovative study designs using the example of the HOPE-study].
Rangoonwala B
Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S82-5. PubMed ID: 15988674
[No Abstract] [Full Text] [Related]
20. Ramipril use in Canada: HOPE or HYPE?
Pilote L
CMAJ; 2003 Mar; 168(5):568-9. PubMed ID: 12615751
[No Abstract] [Full Text] [Related]
[Next] [New Search]
